Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124156623 | 12415662 | 3 | F | 201605 | 20160714 | 20160530 | 20160720 | EXP | GB-AMGEN-GBRSP2016067802 | AMGEN | 61.00 | YR | A | M | Y | 0.00000 | 20160719 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124156623 | 12415662 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, THREE WEEKLY | U | 1056659A | 125031 | 6 | MG | UNKNOWN FORMULATION | Q3W | ||||
| 124156623 | 12415662 | 2 | C | AVASTIN | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, THREE WEEKLY | 16D2252B | 0 | 1200 | MG | Q3W | ||||||
| 124156623 | 12415662 | 3 | C | PALONOSETRON | PALONOSETRON | 1 | 300 MG, UNK | 0 | 300 | MG | |||||||||
| 124156623 | 12415662 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 20 MG (12MG + 8MG),, UNK | 0 | 20 | MG | |||||||||
| 124156623 | 12415662 | 5 | C | PEMETREXED | PEMETREXED | 1 | 775 MG, THREE WEEKLY | 0 | 775 | MG | Q3W | ||||||||
| 124156623 | 12415662 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | 400 MUG, UNK | 0 | 400 | UG | |||||||||
| 124156623 | 12415662 | 7 | C | METOCLOPRAMID | METOCLOPRAMIDE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 124156623 | 12415662 | 8 | C | CARBOPLATIN. | CARBOPLATIN | 1 | UNK UNK, THREE WEEKLY | 0 | Q3W |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124156623 | 12415662 | 1 | Product used for unknown indication |
| 124156623 | 12415662 | 2 | Mesothelioma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124156623 | 12415662 | HO |
| 124156623 | 12415662 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124156623 | 12415662 | Diarrhoea | |
| 124156623 | 12415662 | Dry mouth | |
| 124156623 | 12415662 | Dyspnoea exertional | |
| 124156623 | 12415662 | Increased appetite | |
| 124156623 | 12415662 | Insomnia | |
| 124156623 | 12415662 | Mouth ulceration | |
| 124156623 | 12415662 | Night sweats | |
| 124156623 | 12415662 | Oral pain | |
| 124156623 | 12415662 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124156623 | 12415662 | 1 | 20160428 | 0 | ||
| 124156623 | 12415662 | 2 | 20160427 | 0 | ||
| 124156623 | 12415662 | 3 | 20160427 | 0 | ||
| 124156623 | 12415662 | 4 | 20160427 | 0 | ||
| 124156623 | 12415662 | 5 | 20160427 | 0 | ||
| 124156623 | 12415662 | 6 | 20160427 | 0 | ||
| 124156623 | 12415662 | 7 | 20160427 | 0 |